These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18364108)

  • 1. A novel mutation in the BMPR2 gene in familial pulmonary arterial hypertension.
    Fu LJ; Zhou AQ; Huang MR; Shen SH; Shen J; Zhang ZF; Li F
    Chin Med J (Engl); 2008 Mar; 121(5):399-404. PubMed ID: 18364108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Bone morphogenetic protein type II receptor gene promoter mutation-142G > A in a patient with familial pulmonary arterial hypertension].
    Li W; Hu H
    Zhonghua Yi Xue Za Zhi; 2009 Feb; 89(4):230-4. PubMed ID: 19552837
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations of the TGF-beta type II receptor BMPR2 in pulmonary arterial hypertension.
    Machado RD; Aldred MA; James V; Harrison RE; Patel B; Schwalbe EC; Gruenig E; Janssen B; Koehler R; Seeger W; Eickelberg O; Olschewski H; Elliott CG; Glissmeyer E; Carlquist J; Kim M; Torbicki A; Fijalkowska A; Szewczyk G; Parma J; Abramowicz MJ; Galie N; Morisaki H; Kyotani S; Nakanishi N; Morisaki T; Humbert M; Simonneau G; Sitbon O; Soubrier F; Coulet F; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):121-32. PubMed ID: 16429395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical implications of determining BMPR2 mutation status in a large cohort of children and adults with pulmonary arterial hypertension.
    Rosenzweig EB; Morse JH; Knowles JA; Chada KK; Khan AM; Roberts KE; McElroy JJ; Juskiw NK; Mallory NC; Rich S; Diamond B; Barst RJ
    J Heart Lung Transplant; 2008 Jun; 27(6):668-74. PubMed ID: 18503968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Study of the BMPR2 gene in patients with pulmonary arterial hypertension].
    Portillo K; Santos S; Madrigal I; Blanco I; Paré C; Borderías L; Peinado VI; Roca J; Milà M; Barberà JA
    Arch Bronconeumol; 2010 Mar; 46(3):129-34. PubMed ID: 20096498
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BMPR2 gene rearrangements account for a significant proportion of mutations in familial and idiopathic pulmonary arterial hypertension.
    Aldred MA; Vijayakrishnan J; James V; Soubrier F; Gomez-Sanchez MA; Martensson G; Galie N; Manes A; Corris P; Simonneau G; Humbert M; Morrell NW; Trembath RC
    Hum Mutat; 2006 Feb; 27(2):212-3. PubMed ID: 16429403
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension.
    Machado RD; James V; Southwood M; Harrison RE; Atkinson C; Stewart S; Morrell NW; Trembath RC; Aldred MA
    Circulation; 2005 Feb; 111(5):607-13. PubMed ID: 15699281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. BMPR2 mutations have short lifetime expectancy in primary pulmonary hypertension.
    Sankelo M; Flanagan JA; Machado R; Harrison R; Rudarakanchana N; Morrell N; Dixon M; Halme M; Puolijoki H; Kere J; Elomaa O; Kupari M; Räisänen-Sokolowski A; Trembath RC; Laitinen T
    Hum Mutat; 2005 Aug; 26(2):119-24. PubMed ID: 15965979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a novel mutation in the gene for bone morphogenetic protein receptor II in an Israeli patient with familial primary pulmonary hypertension.
    Cahn A; Meiner V; Leitersdorf E; Berkman N
    Isr Med Assoc J; 2004 Mar; 6(3):156-9. PubMed ID: 15055271
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genes and pulmonary arterial hypertension.
    Sztrymf B; Yaïci A; Girerd B; Humbert M
    Respiration; 2007; 74(2):123-32. PubMed ID: 17318011
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel promoter and exon mutations of the BMPR2 gene in Chinese patients with pulmonary arterial hypertension.
    Wang H; Li W; Zhang W; Sun K; Song X; Gao S; Zhang C; Hui R; Hu H
    Eur J Hum Genet; 2009 Aug; 17(8):1063-9. PubMed ID: 19223935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defective cellular trafficking of the bone morphogenetic protein receptor type II by mutations underlying familial pulmonary arterial hypertension.
    John A; Kizhakkedath P; Al-Gazali L; Ali BR
    Gene; 2015 Apr; 561(1):148-56. PubMed ID: 25688877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High frequency of BMPR2 exonic deletions/duplications in familial pulmonary arterial hypertension.
    Cogan JD; Pauciulo MW; Batchman AP; Prince MA; Robbins IM; Hedges LK; Stanton KC; Wheeler LA; Phillips JA; Loyd JE; Nichols WC
    Am J Respir Crit Care Med; 2006 Sep; 174(5):590-8. PubMed ID: 16728714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutation in the gene for bone morphogenetic protein receptor II as a cause of primary pulmonary hypertension in a large kindred.
    Newman JH; Wheeler L; Lane KB; Loyd E; Gaddipati R; Phillips JA; Loyd JE
    N Engl J Med; 2001 Aug; 345(5):319-24. PubMed ID: 11484688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein receptor-II mutation Arg491Trp causes malignant phenotype of familial primary pulmonary hypertension.
    Zhicheng J; Lihe L; Zhiyan H; Xiansheng C; Yubao Z; Yuejin Y; Rutai H
    Biochem Biophys Res Commun; 2004 Mar; 315(4):1033-8. PubMed ID: 14985116
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship of BMPR2 mutations to vasoreactivity in pulmonary arterial hypertension.
    Elliott CG; Glissmeyer EW; Havlena GT; Carlquist J; McKinney JT; Rich S; McGoon MD; Scholand MB; Kim M; Jensen RL; Schmidt JW; Ward K
    Circulation; 2006 May; 113(21):2509-15. PubMed ID: 16717148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bone morphogenetic protein receptor-2 signaling promotes pulmonary arterial endothelial cell survival: implications for loss-of-function mutations in the pathogenesis of pulmonary hypertension.
    Teichert-Kuliszewska K; Kutryk MJ; Kuliszewski MA; Karoubi G; Courtman DW; Zucco L; Granton J; Stewart DJ
    Circ Res; 2006 Feb; 98(2):209-17. PubMed ID: 16357305
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension.
    Aldred MA; Machado RD; James V; Morrell NW; Trembath RC
    Am J Respir Crit Care Med; 2007 Oct; 176(8):819-24. PubMed ID: 17641158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.
    Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L
    N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers.
    Chida A; Shintani M; Yagi H; Fujiwara M; Kojima Y; Sato H; Imamura S; Yokozawa M; Onodera N; Horigome H; Kobayashi T; Hatai Y; Nakayama T; Fukushima H; Nishiyama M; Doi S; Ono Y; Yasukouchi S; Ichida F; Fujimoto K; Ohtsuki S; Teshima H; Kawano T; Nomura Y; Gu H; Ishiwata T; Furutani Y; Inai K; Saji T; Matsuoka R; Nonoyama S; Nakanishi T
    Am J Cardiol; 2012 Aug; 110(4):586-93. PubMed ID: 22632830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.